Screener
Xenon Pharmaceuticals XENE Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Xenon Pharmaceuticals’s reported figures.
The source filing: Xenon Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338244
FAQ
- What is Xenon Pharmaceuticals's enterprise value?
- Xenon Pharmaceuticals (XENE) reported enterprise value of $5.72B in Q2 2026.
- How has Xenon Pharmaceuticals's enterprise value changed year-over-year?
- Xenon Pharmaceuticals's enterprise value increased by 144.3% year-over-year, from $2.34B to $5.72B.
- What is the long-term trend for Xenon Pharmaceuticals's enterprise value?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's enterprise value has grown at a 34.2% compound annual growth rate (CAGR), from $751.75M to $3.27B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Xenon Pharmaceuticals's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude